Michael Bailey
2017
In 2017, Michael Bailey earned a total compensation of $1.4M as Chief Executive Officer at AVEO Pharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $369,334 |
|---|---|
| Option Awards | $451,076 |
| Salary | $479,655 |
| Other | $68,593 |
| Total | $1,368,658 |
Bailey received $479.7K in salary, accounting for 35% of the total pay in 2017.
Bailey also received $369.3K in non-equity incentive plan, $451.1K in option awards and $68.6K in other compensation.
Rankings
In 2017, Michael Bailey's compensation ranked 7,451st out of 14,666 executives tracked by ExecPay. In other words, Bailey earned more than 49.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,451 out of 14,666 | 49th |
Division Manufacturing | 2,778 out of 5,772 | 52nd |
Major group Chemicals And Allied Products | 900 out of 2,075 | 57th |
Industry group Drugs | 703 out of 1,731 | 59th |
Industry Pharmaceutical Preparations | 550 out of 1,333 | 59th |
Source: SEC filing on April 30, 2019.
Bailey's colleagues
We found three more compensation records of executives who worked with Michael Bailey at AVEO Pharmaceuticals in 2017.
News
AVEO Pharmaceuticals CEO Michael Bailey's 2021 pay jumps 84% to $2.9M
April 26, 2022
AVEO Pharmaceuticals CEO Michael Bailey's 2020 pay rises 1% to $1.6M
April 28, 2021
AVEO Pharmaceuticals CEO Michael Bailey's 2019 pay falls 49% to $1.6M
April 28, 2020
AVEO Pharmaceuticals CEO Michael Bailey's 2018 pay jumps 127% to $3.1M
April 30, 2019